These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18846478)

  • 1. Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain.
    Huang H; Weintraub A; Fang H; Nord CE
    Scand J Infect Dis; 2009; 41(2):158-9. PubMed ID: 18846478
    [No Abstract]   [Full Text] [Related]  

  • 2. Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.
    Carman RJ; Genheimer CW; Rafii F; Park M; Hiltonsmith MF; Lyerly DM
    Anaerobe; 2009 Dec; 15(6):244-8. PubMed ID: 19818865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR-ribotypes 012, 017 and 046 in Sweden, 2008 and 2009.
    Akerlund T; Alefjord I; Dohnhammar U; Struwe J; Noren T; Tegmark-Wisell K;
    Euro Surveill; 2011 Mar; 16(10):. PubMed ID: 21435322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of Clostridium difficile in Scotland.
    Wiuff C; Brown DJ; Mather H; Banks AL; Eastaway A; Coia JE
    J Infect; 2011 Apr; 62(4):271-9. PubMed ID: 21300104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.
    Drudy D; Quinn T; O'Mahony R; Kyne L; O'Gaora P; Fanning S
    J Antimicrob Chemother; 2006 Dec; 58(6):1264-7. PubMed ID: 17018563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different ribotypes in community-acquired Clostridium difficile.
    Bignardi GE; Settle C
    J Hosp Infect; 2008 Sep; 70(1):96-8. PubMed ID: 18511151
    [No Abstract]   [Full Text] [Related]  

  • 8. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm.
    Huang H; Fang H; Weintraub A; Nord CE
    Clin Microbiol Infect; 2009 Dec; 15(12):1170-3. PubMed ID: 19624517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
    Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
    Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic profiling of Clostridium difficile ribotype 176--A multidrug resistant relative to C. difficile ribotype 027.
    Krutova M; Matejkova J; Tkadlec J; Nyc O
    Anaerobe; 2015 Dec; 36():88-90. PubMed ID: 26256807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates.
    Solomon K; Fanning S; McDermott S; Murray S; Scott L; Martin A; Skally M; Burns K; Kuijper E; Fitzpatrick F; Fenelon L; Kyne L
    J Antimicrob Chemother; 2011 Sep; 66(9):1976-82. PubMed ID: 21712239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Clostridium difficile strains isolated from immunosuppressed inpatients in a hospital in Rio de Janeiro, Brazil.
    Balassiano IT; Miranda KR; Boente RF; Pauer H; Oliveira IC; Santos-Filho J; Amorim EL; Caniné GA; Souza CF; Gomes MZ; Ferreira EO; Brazier JS; Domingues RM
    Anaerobe; 2009 Jun; 15(3):61-4. PubMed ID: 19154793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Life-threatening infections with a new strain of Clostridium difficile].
    Krausz S; Bessems M; Boermeester MA; Kuijper EJ; Visser CE; Speelman P
    Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2081-6. PubMed ID: 16201595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile and fluoroquinolones: is there a link?
    Weiss K
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S29-32. PubMed ID: 19303566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory-acquired clostridium difficile polymerase chain reaction ribotype 027: a new risk for laboratory workers?
    Bouza E; Martin A; Van den Berg RJ; Kuijper EJ
    Clin Infect Dis; 2008 Dec; 47(11):1493-4. PubMed ID: 18986267
    [No Abstract]   [Full Text] [Related]  

  • 16. Clostridium difficile ribotype 027-associated disease in children with norovirus infection.
    Lukkarinen H; Eerola E; Ruohola A; Vainionpää R; Jalava J; Kotila S; Ruuskanen O
    Pediatr Infect Dis J; 2009 Sep; 28(9):847-8. PubMed ID: 19636284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile ribotype 027 arrives in Hong Kong.
    Cheng VC; Yam WC; Chan JF; To KK; Ho PL; Yuen KY
    Int J Antimicrob Agents; 2009 Nov; 34(5):492-3. PubMed ID: 19464857
    [No Abstract]   [Full Text] [Related]  

  • 18. A case-control study of community-associated Clostridium difficile infection.
    Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
    J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface layer protein A variant of Clostridium difficile PCR-ribotype 027.
    Spigaglia P; Barbanti F; Mastrantonio P
    Emerg Infect Dis; 2011 Feb; 17(2):317-9. PubMed ID: 21291621
    [No Abstract]   [Full Text] [Related]  

  • 20. [First Danish case of Clostridium difficile ribotype 027].
    Søes LM; Brock I; Torpdahl M; Persson S; Christensen KM; Kemp M; Olsen KE
    Ugeskr Laeger; 2009 May; 171(19):1579-80. PubMed ID: 19419637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.